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INTRODUCTION
Type two diabetes is one of the most prevalent and disabling conditions in older people. 1 More than 40% of all cases of diabetes are diagnosed in older adults (aged > 60 years) and the number of older people with diabetes is expected to dramatically increase in the next 20 years. 2 Diabetes is associated with a wide range of adverse outcomes such as pain, lower limb amputation, increased healthcare costs 3 , falls 4 and cognitive decline. 5 Although treatments for diabetes have improved, the prevention of this condition is of importance. Several potential reversible/modifiable risk factors for diabetes (including obesity, sedentary lifestyle, high blood pressure and blood cholesterol levels)
are common targets for the prevention of diabetes. 6 However, successful treatment of these risk factors has been mixed, with minimal data specifically in older adults 7 , suggesting there may be other potential risk factors that could be treatment targets.
Low vitamin D levels are a potential and easy reversible target for diabetes in older adults.
Hypovitaminosis D (usually defined as low circulating serum 25 hydroxyvitamin D [25OHD]
levels) is a common condition in older people. 8-10 A number of cross-sectional and case-control studies in older adults have reported there is not a significant association between hypovitaminosis D and the presence of diabetes, particularly after adjusting the analyses for the presence of some potential confounders such as obesity. [11] [12] [13] [14] In contrast to younger populations, the depletion of susceptible effects might play an important part in the lack of the association between hypovitaminosis D and diabetes. 15 People with low 25OHD levels in old age may be less prone to onset of diabetes. 16 Unfortunately, this meta-analysis included only three studies concerning older people, and all these studies reported a non-significant association between baseline serum 25OHD status and incident diabetes. 16 Understanding whether hypovitaminosis D is associated with the future onset of diabetes in older adults is of importance, due to the high presence of this condition and since the reversibility of this condition is potentially very easy to address. Given this background, we conducted a systematic review and meta-analysis investigating whether low serum 25OHD (hypovitaminosis D) can predict the onset of diabetes in prospective studies among older adults. References of included articles included were hand-searched to identify additional, potentially relevant publications. Conference abstracts were also considered, and in such instances we contacted the corresponding authors to acquire the data to enable inclusion.
METHODS

This
Data extraction
Two authors (AB, PL) independently recorded data extracted from the selected studies into a standardized Microsoft Excel spreadsheet. Any disagreement was resolved by consensus with a third author (BS). The following information was extracted for each study: i) study characteristics (e.g. sample size, demographics, country in which the study was performed); ii) study setting; iii) number of diabetic people during follow-up; iv) follow-up (in years); v) serum 25OHD levels and methods of assessment of 25OHD; vi) diagnostic criteria used for the diagnosis of diabetes; vii) number and type of covariates used in the multivariate analyses.
If more than two categories for serum 25OHD were included, we defined as low the lowest quantile and used the highest one as the reference group.
Assessment of study quality
Study quality was assessed by two investigators (MS, GB), while another one was available for mediation (NV). The Newcastle-Ottawa Scale (NOS) 21 was used to assess study quality. The NOS assigns a maximum of 9 points based on three quality parameters: selection, comparability, and outcome.
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Statistical analysis
A random effects meta-analysis was undertaken using Comprehensive Meta-Analysis (CMA) version 3 to account for the anticipated heterogeneity. 22 In the primary analyses, pooled RRs and 95% CI (including the number of incident cases of diabetes in low serum 25OHD vs. higher values)
were calculated to synthesize data. In the secondary analyses, we included the HR/OR adjusted for the highest number of covariates available for each study and analyzed together using fully-adjusted RRs.
Study heterogeneity was assessed using the chi-squared and I-squared statistics, assuming that a p<0.05 for the former and a value ≥50% for the latter indicated a significant heterogeneity. 23 Whenever significant heterogeneity existed and ≥4 studies were available, a meta-regression analysis was pre-planned taking as potential moderators: continent in which the study was performed, study setting (community vs. others), follow-up (as continuous, in years), diagnostic criteria used for the diagnosis of diabetes (self-reported vs. others), and number of covariates.
Publication bias was assessed by visually inspection of funnel plots and using the Egger bias test. 24 When ≥3 studies were available, we used the Duval and Tweedie nonparametric trim-and-fill method to account for potential publication bias. Based on the assumption that the effect sizes of all the studies are normally distributed around the center of a funnel plot, in the event of asymmetries, this procedure adjusts for the potential effect of unpublished (trimmed) studies.
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RESULTS
The search identified 4,268 non-duplicated, potentially eligible studies. After excluding 4,229 papers on the grounds of a review of their titles and abstracts, 39 full-text articles were examined.
Of the full texts, 30 were excluded (mainly being cross-sectional studies) and 9 articles [25] [26] [27] [28] [29] [30] [31] [32] [33] were finally included in our meta-analysis (Supplementary Material S1).
Study and patient characteristics
As reported in Table 1 , the 9 studies [25] [26] [27] [28] [29] [30] [31] [32] [33] followed-up 28,258 older participants for a median follow-up period of 7.3 (range: 2-11) years in which 2,863 participants (=10.1% of the baseline population) developed diabetes.
The mean age of the participants was 67.7±4.3 years and the majority were women (64%). All the studies were done among community-dwellers and mainly in Europe (studies=4) and North America (studies=4).
As reported in Table 1 , the majority of the studies used radioimmunoassay (RIA) method for measuring 25OHD, whilst only one 29 chemiluminescence that is considered the gold standard for assessing serum 25OHD levels. 19 Regarding the diagnosis of diabetes, two studies 30,32 used only self-reported information. Other studies used self-reported information, but with a final adjudication by a specialist in one study 25 , with a value of FPG over 126 mg/d in another onel 27 , and with use of anti-diabetic medications in a third study. 29 Two studies used a value of HbA1c over 6.5% for the diagnosis of type 2 diabetes 26,31 , one only a value of FPG over 126 mg/dl 28 and finally one 33 all the criteria suggested by the American Diabetes Association. 20 The quality of the studies was generally of moderate quality as shown by the median eNOS values (median=7; range: 5-9) ( Table 1) .
Unadjusted findings regarding lower 25OHD levels and diabetes
As shown in Figure 1 , 568 older participants from 5,366 with lower vs. 752/8,197 with higher serum 25OHD levels (=10.6% vs. 9.2%) had a diagnosis of diabetes during follow-up period.
Lower 25OHD levels at baseline were associated with a higher risk developing diabetes compared to older people with higher 25OHD levels (6 studies 25, 28, [30] [31] [32] [33] ; n=13,563 ; RR=1.31; 95%CI: 1.11-1.54; p=0.001; I 2 =37%).
No publication bias was found (Egger's test=-0.28; p=0.82) and the trim and fill analysis did not change our results.
Adjusted analyses regarding lower 25OHD levels and diabetes Figure 2 shows the association between lower serum 25OHD levels at the baseline and the onset of diabetes at follow-up after adjusting for potential confounders. The median number of adjustments in the multivariate analyses was 11 (range: 4-17), with all the studies including adiposity estimates, as shown in Table 1 .
In the nine studies [25] [26] [27] [28] [29] [30] [31] [32] [33] included (n=28,258) older participants, we observed that lower 25OHD levels at the baseline increased the risk of future diabetes of 17% (HR=1.17; 95%CI: 1.03-1.33; p=0.02; I 2 =0%). Publication bias was not present (Egger's test=-0.34; p=0.58) and the trim and fill analysis did not change our findings.
Meta-regression analysis
Among the outcomes included in our analyses, no one was affected by high heterogeneity and so meta-regression analyses were run.
DISCUSSION
In this meta-analysis including a total of 9 longitudinal studies and 28,258 older participants, we found evidence that hypovitaminosis D at the baseline was associated with incident diabetes at follow-up, also after adjusting for potential confounders.
It is noteworthy that on their own, none of the longitudinal studies reported a significant association between hypovitaminosis D at baseline and incident diabetes after adjusting for the presence of potential confounders. On the contrary, when we merged the data in a meta-analysis considering a median of 11 potential confounders the presence of hypovitaminosis D at baseline increased the risk of diabetes at follow-up by 17%. Altogether these findings suggest that hypovitaminosis D in older adults may be a potential risk factor for diabetes.
Previous literature, on the contrary, has suggested that hypovitaminosis D is not associated with the onset of diabetes in older adults, which may be due to a number of reasons. First, we could hypothesize that hypovitaminosis D may be a stronger predictor of mortality than diabetes in older people, as shown by a number of papers on this issue. 34-37 Consequently, one hypothesis is that subjects with low serum 25OHD may die before developing diabetes. This hypothesis is somewhat reinforced by our meta-analysis suggesting that probably single studies do not have sufficient power to detect the association between hypovitaminosis D and diabetes, potentially due to the competitive risk of mortality. Second, several conditions are commonly associated with both hypovitaminosis D and/or diabetes. In the elderly, adiposity seems to be the most important in explaining why low 25OHD levels are not associated with diabetes in older people. 13 This hypothesis is supported by some of the previously-mentioned studies, which found that the significant association identified between poor vitamin D status and diabetes disappeared after controlling for BMI or other adiposity measures. 28, 30 Altogether our findings are in agreement with the two previous meta-analyses 16, 38 in the general population including adults of all ages. Thus, our meta-analysis confirms for the first time that hypovitaminosis D is associated with diabetes in the elderly.
Our findings open the question whether or not supplementation with vitamin D could prevent or slow the progression of diabetes older subjects. To the best of our knowledge, only two RCTs have considered vitamin D supplementation in older individuals at higher risk of diabetes. 39 ,40 It appears across these studies that oral vitamin D supplementation has no effect on glucose parameters in participants at higher risk of diabetes. 39, 40 The quality of these studies seems to be adequate, the doses of cholecalciferol used were 700 IU/day or more, and the follow-up was long enough for any significant changes to emerge in the metabolic parameters investigated. 41 Based also on our results, however, future trials are needed to confirm these findings.
The findings of our study should be interpreted within its limitations. First, the observational nature of the studies included does not enable us to elucidate potential pathways responsible of the association between hypovitaminosis D and diabetes. Second, although the analyses made through
HRs suggest a significant association between low serum 25OHD and diabetes, those made through adjusted ORs did not. The latter may be due to the fact only 3 study estimates were included with a more limited sample size. Third, the mean age of the subjects included is about 67 years. More focused investigations regarding very old people are so needed to better understand this association.
Fourth, no gender separated analyses were run (due to the limited number of studies in each gender), even if both serum 25OHD and diabetes are usually different between men and women.
Finally, serum 25OHD was mainly measured with RIA that seems to be a worse method to measure serum 25OHD than chemiluminescence. 19 On the contrary, among the strengths of our work, we can include the large number of subjects included, the number of covariates used in the adjusted analyses, the follow-up period (median=7.3), long if referred to older subjects and the low heterogeneity found in almost all of the outcomes included.
CONCLUSION
Our meta-analysis suggests that hypovitaminosis D is associated with the onset of diabetes in older people after adjusting for other potential risk factors. Since hypovitaminosis D is one of the most frequent conditions in older adults and a paucity of trials have attempted to investigate whether vitamin D supplementation can prevent diabetes, future larger scale studies are needed to confirm if the supplementation with vitamin D could prevent diabetes' developing in older adults.
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